Proceed with caution regarding AI-generated ophthalmic references and abstracts
August 19th 2023Clinicians should be alert to the fact that while artificial intelligence (AI) is capable of generating ideas and references, it is crucial to thoroughly vet and fact-check any medical research content that AI produces.
Read More
Early vitrectomy using silicone oil tamponade for endophthalmitis improves vision
August 8th 2023The US and German collaborative study found performing vitrectomy with silicone oil tamponade to manage postoperative endophthalmitis led to a significant improvement in visual acuity (VA) and had a low complication rate.
Read More
Pegcetacoplan shows increasing beneficial effects after 30 Months of Continuous treatment for GA
August 2nd 2023Data from the 30 month GALE extension study indicated that continuous treatment with pegcetacoplan injection showed increasing beneficial effects over that timeframe in patients with geographic atrophy (GA).
Read More
ASRS 2023: Efficacy and safety of biosimilars ranibizumab-nuna and ranibizumab-eqrn in clinical use
July 30th 2023This study of patients was designed to identify unexpected adverse effects of these new pharmacologic therapies that may not have been observed or anticipated during clinical research trials. The studied drugs were biosimilars to the reference drug ranibizumab.
Read More
ASRS 2023: Premier meeting for retina science and innovation
July 12th 2023ASRS is an international, state-or-the-art event offering something for everyone: scientific papers, posters, panel discussions on controversial issues and techniques, award lectures, a Retina Case Conference, the 25th Annual Film Festival, international symposia, and subspecialty review courses.
Read More